Surgical Management of Congenital Chylothorax in Children

Abstract

Purpose: Aim of the study was to determine the role of surgery in the management of congenital chylothorax (CC).

Methods: We retrospectively reviewed the data of patients with CC requiring medical or surgical treatment postnatally in our institution between January 2001 and March 2009.

Results: Ten patients were treated for CC. We divided our population into 2 groups: group A consisted of patients in whom CC healed after conservative medical treatment (thoracocentesis, pleural drainage, total parental nutrition, somatostatin, intrapleural injections of povidone-iodine), and group B of patients who needed both medical and surgical treatment (pleural abrasion and/or pleurectomy). Conservative postnatal therapy was successful in 50% of cases. Of the 3 patients treated preoperatively with intrapleural injections of povidone-iodine, 2 presented with severe complications. Surgical treatment was successful in all cases, with no surgical complications. Patients in group B had a significantly lower birth term (p=0.0254) and birth weight (p=0.0021) compared to patients in group A. Patients with a massive chylothorax (≥50 mL/kg/day) needed surgery significantly more often than those with chylothorax <50 mL/kg/day (p=0.0119).

Conclusion: The initial postnatal medical management of CC should consist of thoracocentesis, drainage by tube thoracostomy, and total parenteral nutrition. If this treatment fails after 10 days, we propose using alternative therapies such as somatostatin (although its efficacy is not clear) and surgery. Chemical pleurodesis by intrapleural injection of povidone-iodine must be avoided in infants and small babies. Surgical management by pleural abrasion and/or pleurectomy appears to be safe and effective. Early surgical management is proposed for babies with low birth term, birth weight and massive chylothorax >50 mL/kg/day. Long-term follow-up is needed to evaluate the potential consequences of this therapy.

congenital chylothorax - surgical management - pleural abrasion - pleurectomy

References

• 1 Allen EM, van Heeckeren DW, Spector ML. et al . Management of nutritional and infectious complications of postoperative chylothorax in children.  J Pediatr Surg. 1991;  26 (10) 1169-1174
• 2 Azizkhan RG, Canfield J, Alford BA. et al . Pleuroperitoneal shunts in the management of neonatal chylothorax.  J Pediatr Surg. 1983;  18 (6) 842-850
• 3 Beghetti M, La Scala G, Belli D. et al . Etiology and management of pediatric chylothorax.  J Pediatr. 2000;  136 (5) 653-658
• 4 Brissaud O, Desfrer L, Mohsen R. et al . Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone iodine (Betadine).  Arch Dis Child Fetal Neonatal Ed. 2003;  88 (6) F531-533
• 5 Brito T, Oliveira C, Sousa L. et al . Congenital chylothorax: a case report.  Ultrasound Obstet Gynecol. 2003;  21 70-71
• 6 Bulbul A, Okan F, Nuhoglu A. Idiopathic congenital chylothorax presented with severe hydrops and treated with octreotide in term newborn.  J Matern Fetal Noenatal Med. 2009;  22 (12) 1197-1200
• 7 Büttiker V, Hug MI, Burger R. et al . Somatostatin: a new therapeutic option for the treatment of chylothorax.  Intensive Care Med. 2001;  27 1083-1086
• 8 Cleveland K, Zook D, Harvey K. et al . Massive chylothorax in small babies.  J Pediatr Surg. 2009;  44 546-550
• 9 Dendale J, Comet P, Amram D. et al . Le chylothorax de découverte anténatale.  Arch Pediatr. 1999;  6 867-871
• 10 Engum SA, Rescorla FJ, West KW. et al . The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants.  J Pediatr Surg. 1999;  34 (2) 286-290
• 11 Fernandez Alvarez JR, Kalache KD, Grauel EL. Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition.  Am J Perinatol. 1999;  16 (8) 415-420
• 12 Hagay Z, Reece A, Roberts A. et al . Isolated pleural effusion: a prenatal management dilemma.  Obstet Gynecol. 1993;  81 (1) 147-152
• 13 Le Coultre C, Oberhänsli I, Mossaz A. et al . Postoperative chylothorax in children: differences between vascular and traumatic origin.  J Pediatr Surg. 1991;  26 (5) 519-523
• 14 Longaker MT, Laberge JM, Dansereau J. et al . Primary fetal hydrothorax: natural history and management.  J Pediatr Surg. 1989;  24 (6) 573-576
• 15 Mitanchez D, Walter-Nicolet E, Salomon R. et al . Congenital chylothorax: what is the best strategy?.  Arch Dis Child Fetal Neonatal Ed. 2006;  91 F153-154
• 16 Murphy MC, Newmen BM, Rodgers BM. Pleuroperitoneal shunts in the management of persistent chylothorax.  Ann Thorac Surg. 1989;  48 195-200
• 17 Paget-Brown A, Kattwinkel J, Rodgers BM. et al . The use of octreotide to treat congenital chylothorax.  J Pediatr Surg. 2006;  41 (4) 845-847
• 18 Selle JG, Snyder WH, Schreiber JT. Chylothorax: indications for surgery.  Ann Surg. 1973;  177 (2) 245-249
• 19 Watson WJ, Munson DP, Christensen MW. Bilateral fetal chylothorax: results of unilateral in utero therapy.  Am J Perinatol. 1996;  13 (2) 115-117
• 20 Wolff AB, Silen ML, Kokoska ER. et al . Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children.  Ann Thorac. 1999;  68 1053-1057

Correspondence